• An elderly woman with severe enteritis mimicking infectious enteritis

• Nagashima Kazunori

• Kato Takashi, Kimura Taichi, Kishi Kazuma, Baba Urara

• Intestinal Research   2021  Volume.19  No.4 482 ~ 484

• Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model

• Park Ji-Hye

• Kim Da-Hye, Kim Soo-Chan, Ma Hyun-Woo, Park I-Seul, Son Mi-Jeong, Kim Ji-Hyung, Shin Yoo-J...

• Intestinal Research   2021  Volume.19  No.4 478 ~ 481

• Pediatric Crohn¡¯s disease with severe morbidity manifested by gastric outlet obstruction: two cases...

• Kim Eun-Sil

• Park Ji-Hyung, Choe Yon-Ho, Kim Mi-Jin

• Intestinal Research   2021  Volume.19  No.4 472 ~ 477

• Hydroxyurea associated ileocecal valve ulcer: evidence for causality

• Jayaraman Thevaraajan

• Rajaram Ruveena Bhavani, Gan Gin Gin, Hilmi Ida

• Intestinal Research   2021  Volume.19  No.4 468 ~ 471

• Is there a correlation between infliximab trough levels and the development of adverse events in pat...

• Theodoraki Eirini

• Orfanoudaki Eleni, Foteinogiannopoulou Kalliopi, Legaki Evangelia, Gazouli Maria, Koutroubakis Ioann...

• Intestinal Research   2021  Volume.19  No.4 461 ~ 467

• Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderate...

• Kobayashi Taku

• Ito Hiroaki, Ashida Toshifumi, Yokoyama Tadashi, Nagahori Masakazu, Inaba Tomoki, Shikamura Mit...

• Intestinal Research   2021  Volume.19  No.4 448 ~ 460

• High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative...

• Jain Saransh

• Namdeo Divya, Sahu Pabitra, Kedia Saurabh, Sahni Peush, Das Prasenjit, Sharma Raju, Gupta ...

• Intestinal Research   2021  Volume.19  No.4 438 ~ 447

• Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy

• Hayashi Ryohei

• Ueno Yoshitaka, Tanaka Shinji, Onishi Kana, Takasago Takeshi, Wakai Masaki, Naito Toshikatsu,&n...

• Intestinal Research   2021  Volume.19  No.4 430 ~ 437

• Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-...

• Ogata Haruhiko

• Hagiwara Takashi, Kawaberi Takeshi, Kobayashi Mariko, Hibi Toshifumi

• Intestinal Research   2021  Volume.19  No.4 419 ~ 429

• Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn¡¯s disease: 3-year ...

• Hisamatsu Tadakazu

• Suzuki Yasuo, Kobayashi Mariko, Hagiwara Takashi, Kawaberi Takeshi, Ogata Haruhiko, Matsui Tosh...

• Intestinal Research   2021  Volume.19  No.4 408 ~ 418

• Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel diseas...

• Banerjee Rupa

• Pal Partha, Nabi Zaheer, Shava Upender, Ganesh Girish, Reddy D. Nageshwar

• Intestinal Research   2021  Volume.19  No.4 398 ~ 407

• Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerat...

• Hisamatsu Tadakazu

• Kim Hyo-Jong, Motoya Satoshi, Suzuki Yasuo, Ohnishi Yoshifumi, Fujii Noriyuki, Matsushima Nobuk...

• Intestinal Research   2021  Volume.19  No.4 386 ~ 397

• An overview of the gut side of the SARS-CoV-2 infection

• da Luz Bruna Barbosa

• de Oliveira Natalia Mulinari Turin, dos Santos Isabella Wzorek Franca, Paza Luana Zampieron, de Mello Bra...

• Intestinal Research   2021  Volume.19  No.4 379 ~ 385

• Crohn¡¯s disease at radiological imaging: focus on techniques and intestinal tract

• Cicero Giuseppe

• Mazziotti Silvio

• Intestinal Research   2021  Volume.19  No.4 365 ~ 378

• Gut microbiome and checkpoint inhibitor colitis

• Sehgal Kanika

• Khanna Sahil

• Intestinal Research   2021  Volume.19  No.4 360 ~ 364

• Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis?

• Kim You-Sun

• Intestinal Research   2021  Volume.19  No.4 357 ~ 359